Pelenova is a biotechnology company specialized in research, development and production of innovative therapeutic proteins targetting treatment related to skin associated conditions such as chronic ulcers, burns, sores and psoriasis. Founded in 2003, based in Brazil, privately held and backed by venture capital as a result of a spin-off of a research group within the faculty of Medicine of the University of Sao Paulo in Ribeirao Preto.